E-mail Update
Sign Up

Google

Low Prevalence of Hepatitis C Virus Antibodies in Men Who Have Sex With Men Who Do Not Inject Drugs

By Liz Highleyman

Since the early 2000s, doctors in the U.K. and elsewhere in Europe have reported outbreaks of apparently sexually transmitted acute hepatitis C virus (HCV) infection among mostly HIV positive men who have sex with men (MSM).

Yet while a small number of similar cases have also been reported in Australia and in the U.S., the overall prevalence of HCV antibody positivity remains low among MSM who do not inject drugs, according to a Public Health Reports supplement devoted to viral hepatitis.

Despite the recent spate of HCV transmissions linked to sex and non-injection drug use, the authors emphasized that, "Large or repeated percutaneous exposures to blood, such as through transfusion from unscreened donors or injection drug use, have been the primary sources of infection." They added that, "Sexual transmission occurs, but appears to be inefficient compared with other sexually transmitted viruses."

The authors acknowledged that recent reports of increasing HCV infection among HIV positive MSM who are not injection drug users (IDUs) has raised concern about sexual transmission of HCV and prompted some healthcare providers and advocates to suggest that all MSM should be routinely tested for hepatitis C.

To assess whether such routine testing might be valuable, they compared the prevalence of HCV antibodies among non-IDU MSM and "other" (i.e., heterosexual) non-IDU men at sexually transmitted disease clinics and HIV testing and counseling programs in New York City, Seattle, and San Diego during the 1999-2003 period.

They found that among male and female IDUs, the prevalence of detectable HCV antibodies was 47%-57% across the sites, for an overall prevalence of 51%.

By contrast, among 1699 non-IDU MSM, just 26 (1.5%) tested positive for HCV antibodies. Among 3455 "other" non-IDU men, the rate was 3.6%, indicating that the gay men had a lower, rather than higher, rate of HCV positivity.

According to the authors, these findings argue against routine testing of all MSM who do not inject drugs.

"With decreasing resources to support prevention activities in publicly funded clinics, targeting HCV testing to those most likely to be infected is important," they wrote. "Although sexual transmission of HCV is possible, it appears to be inefficient, and testing MSM without a risk factor for which routine HCV is currently recommended is not supported by data in this report or other studies."

The authors do recommend that HIV positive MSM should be tested for HCV infection regardless of reported risk factors, "as coinfection has important implications for progression of and therapy for both diseases."

A countervailing argument in favor of routinely testing all MSM comes from a recent report from Brighton in the U.K. showing that some HIV negative MSM have also acquired apparently sexually transmitted acute HCV infection (though the rate was much lower than that of HIV positive men).

Further, the Public Health Reports study concluded in 2003. In the European cities that have reported acute HCV outbreaks among MSM, there were only a few cases reported in 2000-2003, with the number increasing in the ensuing years. Though similar outbreaks have not yet been reported in the U.S., some experts believe it is only a matter of time.

10/05/07

Reference
J Buffington, PJ Murray, K Schlanger, and others. Low Prevalence of Hepatitis C Virus Antibody in Men Who Have Sex With Men Who Do Not Inject Drugs. Public Health Reports 122 (suppl 2): 63-67. September 2007.